Medicare Enrolled
Dr. Elizabeth Anoia-Loftus, M.D.
Urology Physician · Huntingdon Valley, PA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Anoia-Loftus from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Anoia-Loftus?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Anoia-Loftus
Dr. Elizabeth Anoia-Loftus is an urology physician in Huntingdon Valley, PA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Anoia-Loftus performed 6,894 Medicare services across 2,690 unique beneficiaries.
Between the years covered by Open Payments, Dr. Anoia-Loftus received a total of $9,457 from 48 pharmaceutical and/or device companies across 284 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Anoia-Loftus is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 7% volume in PA
$9,457 industry payments
Medicare Practice Summary
Medicare Utilization ↗6,894
Medicare services
Top 7% in PA for urology physician
2,690
Unique beneficiaries
$28
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~345 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| BCG treatment for bladder cancer | 1,500 | $2 | $5 |
| Botox injection, per unit An injection of onabotulinumtoxinA, a medication used to temporarily relax muscles or reduce gland activity. The dose is measured in units, with this code representing a single unit administered. |
1,425 | $5 | $9 |
| Automated urinalysis An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine. |
1,012 | $2 | $10 |
| Bladder ultrasound after voiding An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder. |
910 | $9 | $67 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
655 | $99 | $293 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
343 | $68 | $209 |
| Chronic care management, first 20 min/month This service covers the first 20 minutes of clinical staff time directed by a healthcare professional each calendar month to manage chronic conditions. |
309 | $51 | $85 |
| Cystourethroscopy A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract. |
166 | $62 | $600 |
| Lower leg neurostimulator electrode insertion A procedure to place an electrode in the lower leg for neurostimulation therapy. |
155 | $98 | $250 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
96 | $120 | $358 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
41 | $109 | $215 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
38 | $66 | $117 |
| Bladder instillation of anti-cancer drug A procedure where an anti-cancer medication is introduced directly into the bladder. This method delivers the treatment locally to the bladder tissue. |
32 | $73 | $207 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
31 | $48 | $79 |
| Initial hospital admission, low complexity Initial hospital inpatient or observation care for a new patient involving straightforward or low-level medical decision making, with at least 40 minutes total time on the date of the encounter. |
30 | $70 | $156 |
| Simple insertion of temporary bladder tube A procedure to place a temporary tube into the bladder. This allows for the drainage of urine from the bladder. |
29 | $45 | $149 |
| Ureteral stent insertion via endoscope A flexible tube is inserted into the ureter using an endoscope to keep the passage open and allow urine to flow from the kidney to the bladder. |
29 | $105 | $1,000 |
| Endoscopic removal of foreign body, stone, or stent from urethra or bladder A procedure to remove a foreign object, stone, or stent from the urethra or bladder using an endoscope. The endoscope is a thin tube with a camera inserted into the urinary tract to locate and extract the item. |
26 | $118 | $507 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
19 | $70 | $246 |
| Endoscopic destruction of bladder/urethra growth, less than 0.5 cm A procedure to remove abnormal tissue growths from the bladder or urethra using an endoscope. This specific code applies when the growths are smaller than 0.5 centimeters. |
17 | $159 | $1,500 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
17 | $143 | $472 |
| Cystoscopy with chemical ablation of bladder A procedure where a camera is used to examine the bladder and a chemical agent is applied to destroy abnormal tissue. |
14 | $131 | $550 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
1.0% high complexity
33.9% medium
65.1% routine
Industry Payment Transparency
Open Payments through 2024 ↗$9,457
Total received (2018-2024)
Avg $1,351/year across 7 years
Top 15% in PA for urology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
48
Companies
284
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$9,144 (96.7%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$313 (3.3%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,811
2023
$2,847
2022
$860
2021
$837
2020
$333
2019
$859
2018
$911
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
BLUEWIND MEDICAL
$1,054
Medtronic, Inc.
$385
ABBVIE INC.
$266
Dendreon Pharmaceuticals LLC
$216
Sumitomo Pharma America, Inc.
$179
Ferring Pharmaceuticals Inc.
$146
Janssen Scientific Affairs, LLC
$144
Astellas Pharma US Inc
$73
Janssen Biotech, Inc.
$67
UROGEN PHARMA, INC.
$66
Axonics, Inc.
$39
Boston Scientific Corporation
$32
PROGENICS PHARMACEUTICALS, INC.
$30
Bayer Healthcare Pharmaceuticals Inc.
$23
Telix Pharmaceuticals
$22
Mission Pharmacal Company
$20
PFIZER INC.
$17
COLOPLAST CORP
$17
IMMUNITYBIO, INC.
$14
Top 3 companies account for 60.7% of 2024 payments
All-time payments by company (2018-2024) ›
Coloplast Corp
$1,481
Dendreon Pharmaceuticals LLC
$1,336
BLUEWIND MEDICAL
$1,054
Astellas Pharma US Inc
$1,045
Medtronic, Inc.
$917
Sumitomo Pharma America, Inc.
$415
Ferring Pharmaceuticals Inc.
$414
ABBVIE INC.
$309
Boston Scientific Corporation
$304
Janssen Biotech, Inc.
$269
Axonics, Inc.
$147
Janssen Scientific Affairs, LLC
$144
Bayer HealthCare Pharmaceuticals Inc.
$133
Bayer Healthcare Pharmaceuticals Inc.
$126
Avadel Specialty Pharmaceuticals, LLC
$125
Mission Pharmacal Company
$120
Progenics Pharmaceuticals, Inc.
$104
UROVANT SCIENCES INC
$97
UROGEN PHARMA, INC.
$91
Allergan, Inc.
$77
TOLMAR Pharmaceuticals, Inc.
$65
Medtronic USA, Inc.
$58
Antares Pharma, Inc.
$53
Endo Pharmaceuticals Inc.
$47
Myovant Sciences Inc.
$44
AbbVie, Inc.
$36
Laborie Medical Technologies Corp.
$34
BOSTON SCIENTIFIC CORPORATION
$33
Myriad Genetic Laboratories, Inc.
$31
PROGENICS PHARMACEUTICALS, INC.
$30
Allergan Inc.
$29
180 Medical, Inc.
$24
Telix Pharmaceuticals
$22
CONMED Corporation
$21
Merck Sharp & Dohme LLC
$20
Merck Sharp & Dohme Corporation
$19
Curium US LLC
$19
UroGen Pharma, Inc.
$18
C. R. BARD, INC. & SUBSIDIARIES
$18
PFIZER INC.
$17
COLOPLAST CORP
$17
MISSION PHARMACAL COMPANY
$16
Tolmar, Inc.
$15
Blue Earth Diagnostics Limited
$15
IMMUNITYBIO, INC.
$14
AbbVie Inc.
$13
Sun Pharmaceutical Industries Inc.
$13
Hollister Incorporated
$12
Top 3 companies account for 40.9% of all-time payments
Associated products mentioned in payments ›
ADSTILADRIN · AIRSEAL · AMS 700 · ANKTIVA · AVEED · Androgel · Axonics · Axonics r-SNM System · Axumin · BOTOX · BOTOX THERAPEUTIC · ELIGARD · ERLEADA · Erleada · FIRMAGON · GEMTESA · GENERAL THERAPIES · GENERAL UTERINE TISSUE REMOVAL · ILLUCCIX · INFUGEM · INTERSTIM · Isiris aStent Removal Device · JATENZO · JELMYTO · KEYTRUDA · LITHOVUE · LithoVue · Luja Coude · Lupron · MYRBETRIQ · Myrbetriq · NOCDURNA · NURO · Noctiva · Nubeqa · ORGOVYX · PROVENGE · PYLARIFY · Prolaris · REVI · Rezum Generator · TOROSA · URIBEL · URIBEL TABS · Uribel · VaPro · XIAFLEX · XTANDI · XYOSTED · Xofigo · Xtandi · rezum Generator
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (97%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Urology physicians within 10 mi
318
Per 100K population
36.9
County median income
$111,521
Nearest hospital
HOLY REDEEMER HOSPITAL AND MEDICAL CENTER
3.1 mi
3.1 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Anoia-Loftus is a clinical cardiology specialist, with above-average Medicare volume (top 7% in PA), with low-engagement industry engagement in the top 15% of PA peers, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Anoia-Loftus experienced with bcg treatment for bladder cancer?
Based on Medicare claims data, Dr. Anoia-Loftus performed 1,500 bcg treatment for bladder cancer services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Anoia-Loftus receive payments from pharmaceutical companies?
Yes. Dr. Anoia-Loftus received a total of $9,457 from 48 companies across 284 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Anoia-Loftus's costs compare to other urology physicians in Huntingdon Valley?
Dr. Anoia-Loftus's average Medicare payment per service is $28. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Anoia-Loftus) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Urology Physicians in Huntingdon Valley
Browse urology physicians in Huntingdon Valley ranked by procedure volume and transparency data.
Highest volume
Top Urology Physicians in PA
Urology physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Urology Physicians in PA
Which PA urology physicians receive the most from drug and device companies.
By company
Coloplast Corp Payments to Doctors
See all physicians who received payments from Coloplast Corp.
By company
Dendreon Pharmaceuticals LLC Payments to Doctors
See all physicians who received payments from Dendreon Pharmaceuticals LLC.
By company
BLUEWIND MEDICAL Payments to Doctors
See all physicians who received payments from BLUEWIND MEDICAL.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology